EQL Pharma AB (publ) appoints Anna Jönsson as permanent Chief Financial Officer (CFO). She will take up the post of CFO immediately. Anna Jönsson has previously been CFO of the listed companies Amniotics AB and Respiratorius AB. She also has extensive experience from an accounting firm.

Anna has worked with EQL's accounting for several years and has been the accounting manager since this spring. She thus knows the company well and is appreciated by all employees. Among other things, she has since last spring, together with the acting CFO, driven the work of streamlining and integrating the company's finance function. We can now, with less effort and higher precision, produce materials and reports to follow up the company's operations. Furthermore, we also have a better basis for making financial and strategic decisions, which is vital for a company in a rapid growth phase, says Christer Fåhraeus, CEO of EQL Pharma.

Emanuel Eriksson has been acting CFO since last spring until a long-term solution was in place and he will continue work with investments.

For further information, please contact:
Christer Fåhraeus
CEO, EQL Pharma AB (publ)

Phone: +46 (0) 705 - 60 90 00
E-mail: christer.fahraeus@eqlpharma.com
Website: www.eqlpharma.com

Eql Pharma AB (Publ) briefly
EQL Pharma AB specializes in developing and selling generics, ie pharmaceuticals that are medically equivalent to reference pharmaceuticals. The company currently has upwards of 20 niche generics (ie generics with limited competition apart from the reference pharmaceutical) approved in the Nordic markets. In addition to these, there is a significant pipeline of additional niche generics for launch in 2021 and beyond. The business is currently entirely focused on prescription pharmaceuticals, including hospital products, in the Nordic region and in selected European markets. EQL Pharma AB conducts its operations in Lund and is listed on the Spotlight Stock Market. EQL Pharma AB conducts extensive development work in collaboration with leading contract manufacturers and pharmaceutical companies in the EU and Asia, among others.

https://news.cision.com/eql-pharma/r/eql-pharma-appoints-permanent-cfo,c3473493

https://mb.cision.com/Main/11664/3473493/1510804.pdf

(c) 2021 Cision. All rights reserved., source Press Releases - English